HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Clissa Selected Research

Anemia

12/2012Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Clissa Research Topics

Disease

2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2012 - 02/2011
1Anemia
12/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2011

Drug/Important Bio-Agent (IBA)

2Phosphoinositide Phospholipase CIBA
05/2012 - 02/2011
2Azacitidine (5 Azacytidine)FDA Link
05/2012 - 02/2011
1ErythropoietinFDA Link
12/2012
1Phospholipase C betaIBA
05/2012
1Proteins (Proteins, Gene)FDA Link
05/2012
1Valproic Acid (Depakote)FDA LinkGeneric
02/2011

Therapy/Procedure

1Therapeutics
05/2012